Treatment for Helicobacter pylori in children. Recent advances;Eradicazione dell'Helicobacter pylori nei bambini. Recenti progressi

Recenti Progressi in Medicina

Volumn 97, Issue 9, 2006, Pages 472-476

  Lionetti, Elena ^a   Fico, Stefania ^a   Maurogiovanni, Giovanni ^b   Cavallo, Luciano ^a   Francavilla, Ruggiero ^a  

^a POLICLINICO   (Italy)

^b Dipartimento di Biomedicina dell'Età Evolutiva ^*

Author keywords

Antibiotic resistance; Children; Helicobacter pylori; Peptic ulcer; Probiotics; Sequential treatment; Triple therapies; Vaccines

Indexed keywords

ANTIBIOTIC AGENT; PROBIOTIC AGENT; PROTON PUMP INHIBITOR;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; CONTROLLED STUDY; DRUG EFFICACY; HELICOBACTER PYLORI; HUMAN; SYMPTOMATOLOGY; UNSPECIFIED SIDE EFFECT;

CHILD; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS;

EID: 33751179003     PISSN: 00341193     EISSN: 00341193     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Go MF. Review article: natural history and epidemiology of Helicobacter pylori infection. Aliment Pharmacol Ther 2002; 16(suppl 1): 3-15.
2. NIH Consensus Statement. Helicobacter pylori in peptic ulcer disease. 1994; 7-9.
3. Vaira D, Gatta L, Ricci C, D'Anna L, Miglioli M. Helicobacter pylori: diseases, tests and treatment. Digest Liver Dis 2001; 33: 788-94.
4. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784-9.
5. Blaser MJ, Chyou PH, Normura A. Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer and duodenal ulcer risk. Cancer Res 1995; 55: 562-5.
6. Czinn SJ. Helicobacter pylori infection: detection, investigation, and management. J Pediatr 2005; 146(3 suppl): S21-6.
7. Kato S, Sherman PM. What is new related to Helicobacter Pylori infection in children and teenagers? Arch Pediatr Adolesc Med 2005; 159: 415-21.
8. Gold BD, Colletti RB, Abbott M, Czinn SJ, Elitsur Y, Hassall E, et al. and North American Society for Pediatric Gastroenterology and Nutrition. Helicobacter pylori infection in children: recommendations for diagnosis and treatment. J Pediatr Gastroenterol Nutr 2000; 31: 490-7.
9. Malfertheiner P, Megraud F, O'Morain C, Hungin AP, Jones R, Axon A, et al. and European Helicobacter Pylori Study Group (EHPSG). Current concepts in the management of Helicobacter pylori infection - the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 2002; 16: 167-80.
10. Uc A, Chong SKF. Treatment of Helicobacter pylori gastritis improves dyspeptic symptoms in children. J Pediatr Gastroenterol Nutr 2002; 34: 281-5.
11. Tindberg Y, Blennow M, Glanstrom M. Clinical symptoms and social factors in a cohort of children spontaneously clearing Helicobacter pylori infection. Acta Pediatrica 1999; 88: 631-5.
12. Rothenbacher D, Bode G, Adler G, Brenner H. History of antibiotic treatment and prevalence of Helicobacter pylori infection among children: results of a population-based study. J Clin Epidemiol 1998; 51: 267-71.
13. Magista AM, Ierardi E, Castellaneta S, Miniello VL, Lionetti E, Francavilla A, et al. Helicobacter pylori status and symptom assessment two years after eradication in pediatric patients from a high prevalence area. J Pediatr Gastroenterol Nutr 2005; 40: 312-8.
14. Oderda G, Rapa A, Bona G. A systematic review of Helicobacter pylori eradication: treatment schedules in children. Aliment Pharmacol Ther 2000; 14: 56-60.
15. Kato S, Konno M, Maisawa S, Tajiri H, Yoshimura N, Shimizu T, et al. Results of triple eradication therapy in Japanese children: a retrospective multicenter study. J Gastroenterol. 2004; 39: 838-43.
16. Gottrand F, Kalach N, Spyckerelle C, Guimber D, Mougenot JF, Tounian P, et al. Omeprazole combined with amoxicillin and clarithromycin in the eradication of Helicobacter pylori in children with gastritis: A prospective randomized double-blind trial. J Pediatr 2001; 139: 664-8.
17. Oderda G, Marinello D, Lerro P, Kuvidi M, de'Angelis GL, Ferzetti A, et al. Dual vs. triple therapy for childhood Helicobacter pylori gastritis: a double-blind randomized multicentre trial. Helicobacter 2004; 9: 293-301.
18. Deltenre M, Ntounda R, Jonas C, et al. Eradication of Helicobacter pylori: why does it fail? Ital J Gastroenterol Hepatol 1998; 30(suppl 3): S326-8.
19. Koletzko S, Richy F, Bontems P, Crone J, Kalach N, Monteiro ML, et al. Prospective multicentre study on antibiotic resistance of Helicobacter pylori strains obtained from children living in Europe. Gut 2006 Apr 7; [Epub ahead of print].
20. Huang JQ, Hunt RH. Are one-week anti-Helicobacter pylori treatments more effective in patients with peptic ulcer disease than in those with non ulcer dyspepsia? A meta-analysis. Am J Gastroenterol 1998; 93: 1639.
21. Van Doorn LJ, Schneeberger PM, Nohuan N, Plaisier AP, Quint WGV, de Boer WA. Importance of Helicobacter pylori cagA and vacA status for the efficacy of antibiotic treatment. Gut 2000; 46: 321-6.
22. Francavilla R, Lionetti E, Castellaneta SP, Magista AM, Boscarelli G, Piscitelli D, et al. Improved efficacy of 10-day sequential treatment for Helicobacter pylori eradication in children: a randomized trial. Gastroenterology 2005; 129: 1414-9.
23. Zullo A, Vaira D, Vakil N, Hassan C, Gatta L, Ricci C, et al. High eradication rates of Helicobacter pylori with a new sequential treatment. Aliment Pharmacol Ther 2003; 17: 719-26.
24. Zullo A, Rinaldi V, Winn S, Meddi P, Lionetti R, Hassan C, et al. A new highly effective short-term therapy schedule for Helicobacter pylori eradication. Aliment Pharmacol Ther 2000; 14: 715-8.
25. De Francesco V, Zullo A, Hassan C, Faleo D, Ierardi E, Panella C, Morini S. Two new treatment regimens for Helicobacter pylori eradication: a randomised study. Digest Liver Dis 2001; 33: 676-9.
26. De Francesco V, Della Valle N, Stoppino V, Amoruso A, Muscatiello N, Panella C, Ierardi E. Effectiveness and pharmaceutical cost of sequential treatment for Helicobacter pylori in patients with non-ulcer dyspepsia. Aliment Pharmacol Ther 2004; 19: 1-6.
27. De Francesco V, Zullo A, Margotta M, Marangi S, Burattini O, Berloco P, et al. Sequential treatment for Helicobacter pylori does not share the risk factors of triple therapy failure. Aliment Pharmacol Ther 2004; 19: 407-14.
28. Cremonini F, Di Caro S, Covino M, Armuzzi A, Gabrielli M, Santarelli L, et al. Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study. Am J Gastroenterol 2002; 97: 2744-9.
29. Cremonini F, Canducci F, Di Caro S, Santarelli L, Armuzzi A, Gasbarrini G, Gasbarrini A. Helicobacter pylori treatment: a role for probiotics? Dig Dis 2001; 19: 144-7.
30. Fuller R. Probiotics in human medicine. Gut 1991; 32: 439-42.
31. Nista EC, Candelli M, Cremonini F, Cazzato IA, Zocco MA, Franceschi F, et al. Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial. Aliment Pharmacol Ther 2004; 20: 1181-8.
32. Lionetti E, Miniello VL, Castellaneta SP, De Canio A, Magistà AM, Bucci N, et al. The effect of oral administration of Lactobacillus reuteri on antibiotic-associated gastrointestinal side effects during helicobacter pylori eradication therapy. Digestive and Liver Disease 2006: 38(A1-A37): A26.
33. Permin H, Andersen LP. Inflammation, immunity, and vaccines for Helicobacter infection. Helicobacter 2005; 10 (suppl 1): 21-5.